scleroderma http://blog.lib.umn.edu/netl0020/scleroderma/ en Copyright 2013 Fri, 16 May 2008 01:42:43 +0000 http://www.sixapart.com/movabletype/?v=4.31-en http://blogs.law.harvard.edu/tech/rss relaxin 3 Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial.

From: Annals of internal medicine
Date: 2000
Volume: 132
Issue: 11
ISSN: 0003-4819
Pages: 871-879

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/relaxin_3.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/relaxin_3.html Fri, 16 May 2008 01:42:43 +0000 relaxin 2 The Effect of Relaxin Treatment on Skeletal Muscle Injuries.

From: The American journal of sports medicine
Date: 2005
Volume: 33
Issue: 12
ISSN: 0363-5465
Pages: 1816-1824

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/relaxin_2.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/relaxin_2.html Fri, 16 May 2008 01:38:33 +0000 relaxin 1 Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial.

From: Annals of internal medicine
Date: 2000
Volume: 132
Issue: 11
ISSN: 0003-4819
Pages: 871-879

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/relaxin_1.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/relaxin_1.html Fri, 16 May 2008 01:33:09 +0000 23 A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.

From: Journal of the American Academy of Dermatology
Date: 2006
Volume: 54
Issue: 3
ISSN: 0190-9622
Pages: 440-447

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/23.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/23.html Fri, 16 May 2008 01:28:56 +0000 22 pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

From: Alimentary pharmacology

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/22.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/22.html Fri, 16 May 2008 01:27:55 +0000 21 Reduced Exercise Capacity and Stress-Induced Pulmonary Hypertension in Patients With Scleroderma*.

From: Chest
Date: 2006
Volume: 130
Issue: 1
ISSN: 0012-3692
Pages: 176-181

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/21.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/21.html Fri, 16 May 2008 01:27:06 +0000 20 Reduced Exercise Capacity and Stress-Induced Pulmonary Hypertension in Patients With Scleroderma*.

From: Chest
Date: 2006
Volume: 130
Issue: 1
ISSN: 0012-3692
Pages: 176-181

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/20.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/20.html Fri, 16 May 2008 01:26:04 +0000 19 Reduced Exercise Capacity and Stress-Induced Pulmonary Hypertension in Patients With Scleroderma*.

From: Chest
Date: 2006
Volume: 130
Issue: 1
ISSN: 0012-3692
Pages: 176-181

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/19.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/19.html Fri, 16 May 2008 01:25:02 +0000 18 Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.

From: Rheumatology
Date: 2006
Volume: 45
Issue: 8
ISSN: 1462-0324
Pages: 1005-1008

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/18.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/18.html Fri, 16 May 2008 01:23:26 +0000 17 Scleroderma: it has been a long hard journey.

From: Internal medicine journal
Date: 2006
Volume: 36
Issue: 8
ISSN: 1444-0903
Pages: 519-523

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/17.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/17.html Fri, 16 May 2008 01:22:20 +0000 16 Systemic and Localized Scleroderma in Children: Current and Future Treatment Options.

From: Paediatric drugs
Date: 2006
Volume: 8
Issue: 2
ISSN: 1174-5878
Pages: 85-97

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/16.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/16.html Fri, 16 May 2008 01:18:29 +0000 15 Is scleroderma an autoantibody mediated disease?.

From: Current opinion in rheumatology
Date: 2006
Volume: 18
Issue: 6
ISSN: 1040-8711
Pages: 579-581

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/15.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/15.html Fri, 16 May 2008 01:17:38 +0000 14 Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.

From: Clinical and experimental immunology
Date: 2006
Volume: 146
Issue: 2
ISSN: 0009-9104
Pages: 362-370

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/14.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/14.html Fri, 16 May 2008 01:16:50 +0000 scleroderma 13 A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

From: Gut
Date: 2006
Volume: 55
Issue: 12
ISSN: 0017-5749
Pages: 1697-1703

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/scleroderma_13.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/scleroderma_13.html Fri, 16 May 2008 01:15:50 +0000 scleroderma 12 Mechanisms of Disease: leukotrienes and lipoxins in scleroderma lung disease-insights and potential therapeutic implications.

From: Nature clinical practice rheumatology
Date: 2007
Volume: 3
Issue: 1
ISSN: 1745-8382
Pages: 43-51

]]> http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/scleroderma_12.html http://blog.lib.umn.edu/netl0020/scleroderma/2008/05/scleroderma_12.html Fri, 16 May 2008 01:14:28 +0000